FECRI publishes breast cancer findings

RESEARCHERS at the Fiona Elsey Cancer Research Institute have published their research findings on triple negative breast cancer.

The paper was published in Current Oncology and focuses on how different treatments can affect the disease.

FECRI director Professor George Kannourakis said the research showcases the developments being achieved at the institute.

“This publication is a great example of the relevant and ground-breaking work that the team here at the institute are doing into the immunology of cancer,” he said.

“Our program is building great momentum and will continue to produce outcomes.”

Alongside Professor Kannourakis, contributors to the paper included researches Dr Aparna Jayachandran, Dr Sushma Rao and Dr Prashanth Prithviraj, and DR Arpita Poddar.

Dr Jayachandran is the institute’s head of breast cancer group and said their research is a step forward in understanding triple negative breast cancer.

“This works sets a future research path for the development of new and improved diagnostic and therapeutic options for TNBC patients,” she said.

With three PhD students and 17 staff members, FECRI’s work centres around how immunology can assist in cancer treatments.

The research paper has been summarised in a YouTube video available via FECRI’s channel.

It’s estimated in the paper that triple negative breast cancer accounts for 15 to 20 per cent of all breast cancer diagnoses.